汤臣倍健：预计2023年公司销售费用率较2022年略微下降
汤臣倍健3月22日在投资者互动平台表示，预计2023年公司销售费用率较2022年略微下降。 中康CMH零售市场数据显示，2022年中国药店膳食营养补充剂整体增速为-1.7%，汤臣倍健增速为3.2%，公司在药店渠道所处行业的份额稳中有升。线上渠道准入门槛较低品牌众多，竞争相对激烈。公司坚持品牌和运营双轮驱动推动线上业务持续健康发展。
Statement:
The content of this article does not represent the views of fxgecko website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!
Reaction to former President Donald Trump's indictment By Reuters
China's JD.com to spin off industrial, property units in Hong Kong float By Reuters
Related News
